TALS logo

Talaris Therapeutics, Inc. Common Stock


TALS: Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.


Show TALS Financials

Consumer Interest
SEC Filings

Recent trades of TALS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by TALS's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of TALS in WallStreetBets Daily Discussion


Recent insights relating to TALS

CNBC Recommendations

Recent picks made for TALS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TALS

Corporate Flights

Flights by private jets registered to TALS